Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley, I Anna S Olsson
{"title":"Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review.","authors":"Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley, I Anna S Olsson","doi":"10.1136/bmjos-2018-000016","DOIUrl":null,"url":null,"abstract":"<p><p></p><p><strong>Objectives: </strong>The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010).</p><p><strong>Methods: </strong>We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores-one for methodological quality, one for regulatory compliance-were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal.</p><p><strong>Results: </strong>Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size.</p><p><strong>Conclusions: </strong>General methodological standards improved gradually over a period of 8-10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington's. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards.</p>","PeriodicalId":9212,"journal":{"name":"BMJ Open Science","volume":"3 1","pages":"e000016"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715942/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjos-2018-000016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 3
Abstract
Objectives: The amyotrophic lateral sclerosis (ALS) research community was one of the first to adopt methodology guidelines to improve preclinical research reproducibility. We here present the results of a systematic review to investigate how the standards in this field changed over the 10-year period during which the guidelines were first published (2007) and updated (2010).
Methods: We searched for papers reporting ALS research on SOD1 (superoxide dismutase 1) mice published between 2005 and 2015 on the ISI Web of Science database, resulting in a sample of 569 papers to review, after triage. Two scores-one for methodological quality, one for regulatory compliance-were built from weighted sums of separate sets of items, and subjected to multivariable regression analysis, to assess how these related to publication year, type of study, country of origin and journal.
Results: Reporting standards improved over time. Of papers published after the first ALS guidelines were made public, fewer than 9% referred specifically to these. Of key research parameters, only three (genetic background, number of transgenes and group size) were reported in >50% of the papers. Information on housing conditions, randomisation and blinding was absent in over two-thirds of the papers. Group size was among the best reported parameters, but the majority reported using fewer than the recommended sample size and only two studies clearly justified group size.
Conclusions: General methodological standards improved gradually over a period of 8-10 years, but remained generally comparable with related fields with no specific guidelines, except with regard to severity. Only 11% of ALS studies were classified in the highest severity level (animals allowed to reach death or moribund stages), substantially below the proportion in studies of comparable neurodegenerative diseases such as Huntington's. The existence of field-specific guidelines, although a welcome indication of concern, seems insufficient to ensure adherence to high methodological standards. Other mechanisms may be required to improve methodological and welfare standards.
目的:肌萎缩性侧索硬化症(ALS)研究界是最早采用方法学指南来提高临床前研究可重复性的研究团体之一。我们在此提出了一项系统综述的结果,以调查该领域的标准在指南首次发布(2007年)和更新(2010年)的10年期间是如何变化的。方法:我们在ISI Web of Science数据库中检索2005年至2015年间发表的关于SOD1(超氧化物歧化酶1)小鼠ALS研究的论文,经分类后获得569篇论文。两个分数——一个是方法质量,一个是法规遵从性——是由独立项目集的加权和建立起来的,并经过多变量回归分析,以评估这些与出版年份、研究类型、原产国和期刊的关系。结果:报告标准随着时间的推移而提高。在第一份ALS指南公布后发表的论文中,只有不到9%的论文专门提到了这些。在关键的研究参数中,只有遗传背景、转基因数量和群体大小三个参数的报道占比大于50%。超过三分之二的论文缺少关于住房条件、随机化和盲法的信息。组大小是报告的最佳参数之一,但大多数报告使用的样本量少于推荐的样本量,只有两项研究明确证明了组大小的合理性。结论:一般的方法标准在8-10年间逐步改进,但除了严重程度外,与没有具体指南的相关领域总体上保持可比性。只有11%的ALS研究被归类为最高严重程度(允许动物达到死亡或垂死阶段),大大低于类似神经退行性疾病(如亨廷顿氏病)的研究比例。具体领域准则的存在虽然令人欢迎地表示关切,但似乎不足以确保遵守高方法标准。可能需要其他机制来改进方法和福利标准。